ArticleDigestive diseases and sciences2022

No Benefit of Continuing 5-Aminosalicylates in Patients with Crohn's Disease Treated with Anti-metabolite Therapy.

Dominic Picetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.